GeekWire Awards 2025 revealed: Community ‘alive and well’ at annual celebration of best in tech
On behalf of the Cancer AI Alliance, Brian Bot accepted GeekWire’s Health Innovation of the Year award, saying it “speaks to the value of this community and how we can work together to solve really difficult problems."
Immunotherapy helps certain cancer patients avoid surgery: ‘We hope this is the future
Dr. Stacey Cohen provided context around a new study: “...as we move to an age where nonoperative management could be a new standard of care with durable and effective treatments, that’s very exciting for patients and providers alike.”
An at-home cervical cancer screening device was OK‘d by the FDA
Dr. Barbara Goff explained advantages of the new at-home cancer screening device: “It expands cervical cancer screening to more women, which is good. And it makes [screening] more comfortable, which is also good.”
Addressing the infectious disease challenges in immunocompromised patients
Dr. Josh Hill discussed how “immune compromised patients are those that we need to study the most carefully, because they are sometimes at the most risk for the infection or worse outcomes from infectious diseases."
What a Prostate Cancer Diagnosis Like Biden’s Means for Patients
Dr. Dan Lin shared his thoughts on how advances in prostate cancer treatment have changed patient outcomes, saying “Life is measured in years now, not months.”
Fred Hutch physicians stress hope after Biden's prostate cancer prognosis
Dr. Dan Lin discussed Biden’s prostate cancer prognosis, “...he has years to live with this diagnosis. We don’t see anything that’s been released that suggests there’s impending doom..." Dr. Evan Yu was also interviewed. Similar coverage ran on Q13.
Biden’s prostate cancer diagnosis is unusual but not unheard of, doctors say
Dr. Pete Nelson explained a possible therapy option: “...patients like Biden have a more than 90% chance of responding to therapies that lower testosterone...” Similar coverage ran in The Washington Post, Scientific American and KIRO-TV.
WA vaccine scientists push back against FDA changes around COVID shots
Dr. Holly Janes pointed out that a new proposal for evaluating updated COVID vaccines is “unclear as to how and whether that trial would be feasible to conduct on the timescale that would be needed.”
HIV’s most promising breakthrough has taken a hit
Dr. Jim Kublin explained that approaches using the mRNA platform for developing an HIV vaccine “are not at all dead in the water” despite mild side effects observed in a recent study.